Stocks and Investing Stocks and Investing
Tue, August 14, 2018
Mon, August 13, 2018

Christopher Marai Maintained (ALNY) at Sell with Decreased Target to $73 on, Aug 13th, 2018


Published on 2024-10-26 07:57:13 - WOPRAI, Christopher Marai
  Print publication without navigation


Christopher Marai of Nomura, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Sell with Decreased Target from $86 to $73 on, Aug 13th, 2018.

Christopher, nor any peers, have made any analyst calls on ALNY in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources